**Core Concept**
Imipramine, a tricyclic antidepressant (TCA), has been found to have a beneficial effect in treating nocturnal enuresis, particularly in children. This effect is thought to be due to its anticholinergic properties, which help to reduce bladder contraction and increase bladder capacity. Additionally, imipramine may also have a role in modifying the neurotransmitter balance in the central nervous system, influencing the regulation of sleep and urinary function.

**Why the Correct Answer is Right**
Imipramine's anticholinergic effects are primarily mediated through its blockade of muscarinic acetylcholine receptors (mAChRs), particularly M2 receptors in the bladder. This blockade reduces the contraction of the detrusor muscle, allowing for increased bladder capacity and reduced nocturnal urine production. Furthermore, imipramine has been shown to have a slight effect on the serotonin and norepinephrine reuptake inhibition, which may also contribute to its efficacy in treating nocturnal enuresis. The exact mechanisms of imipramine's action on nocturnal enuresis are not fully understood, but its anticholinergic properties are thought to play a significant role.

**Why Each Wrong Option is Incorrect**
**Option B:** Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) and is not typically used to treat nocturnal enuresis.
**Option C:** Phenelzine is a monoamine oxidase inhibitor (MAOI) and is not commonly used for this indication.
**Option D:** Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) and is not typically used to treat nocturnal enuresis.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that imipramine's efficacy in treating nocturnal enuresis is not solely due to its antidepressant properties, but rather its unique anticholinergic effects. This distinction highlights the importance of considering multiple mechanisms of action when selecting a medication for a particular indication.

**✓ Correct Answer: A. Imipramine**